Novartis sues FDA over its stance on Sanofi blockbuster’s exclusivity

Novartis’ generic drug subsidiary Sandoz has sued the FDA, claiming the agency is wrongly protecting Sanofi’s blockbuster multiple sclerosis drug Aubagio from generic competition.